TuHURA Biosciences (HURA) vs NRX Pharmaceuticals (NRXP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
NRX Pharmaceuticals (NRXP) has outperformed TuHURA Biosciences (HURA) over the past year, losing 19.9% versus a loss of 24.0%. Over five years, NRXP leads with a -97.2% price change compared with -99.9% for HURA. TuHURA Biosciences is the larger company by market cap ($124.9 million vs $123.4 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HURA | NRXP |
|---|---|---|
| Share price | $1.96 | $2.85 |
| Market cap | $124.90M | $123.39M |
| 1-day change | +1.55% | -1.38% |
| YTD return | +158.92% | +5.17% |
| 1-year return | -24.03% | -19.94% |
| 5-year return | -99.87% | -97.22% |
| EPS (TTM) | $-0.54 | $-0.58 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.43 | $5.06 |
| 52-week low | $0.41 | $1.62 |
| Distance from 52-week high | -42.86% | -43.62% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +310.20% | +1250.88% |
| Average volume | 244.46K | 858.06K |
| Shares outstanding | 63.73M | 43.30M |
| Employees | 22 | 29 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About TuHURA Biosciences
HURA stock →TuHURA Biosciences, Inc., a clinical stage immuno-oncology company, that develops novel technologies for the treatment of cancer immunotherapies. The company's lead product candidate includes IFx2.0, an innate immune agonist designed to overcome primary resistance to checkpoint inhibitors.
Health Care · Biotechnology: Pharmaceutical Preparations · 22 employees
About NRX Pharmaceuticals
NRXP stock →NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder (PTSD), and schizophrenia in the United States. It operates through NRx and Dura segments.
Health Care · Biotechnology: Pharmaceutical Preparations · 29 employees
HURA vs NRXP FAQ
Which is bigger, TuHURA Biosciences or NRX Pharmaceuticals?
TuHURA Biosciences (HURA) is larger, with a market capitalization of $124.90M compared with $123.39M for NRX Pharmaceuticals (NRXP).
Which stock has performed better over the past year, HURA or NRXP?
NRXP returned -19.94% over the past 12 months, compared with -24.03% for HURA (price return, excluding dividends). Past performance does not predict future results.
Are TuHURA Biosciences and NRX Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.